CTLT vs IRD
CTLT (CTLT) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
CTLT does not have a complete income-statement cache yet.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
IRD currently screens at market cap $35.7M.
Not investment advice. Open the CTLT and IRD stock pages for the full models.
Not investment advice.